Ischemic stroke is a leading cause of morbidity and mortality worldwide. Thrombolytic therapy, the only established treatment to reduce the neurological deficits caused by ischemic stroke, is limited by time window and potential complications. | Caveolin-1 and MLRs: A potential target for neuronal growth and neuroplasticity after ischemic stroke